Gene · 10666
Papers4,079
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 4,079
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploiting innate immunity for cancer immunotherapy. | Mol Cancer | 2023 | 38008741 | PubTator, text mining | PubMed |
| Associations of myeloid cells with cellular and humoral responses following vaccinations in patients with neuroimmunological diseases. | Nat Commun | 2023 | 38007484 | PubTator, text mining | PubMed |
| Therapeutic avenues for γδ T cells in cancer. | J Immunother Cancer | 2023 | 38007241 | PubTator, text mining | PubMed |
| Immune-Cell-Based Therapy for COVID-19: Current Status. | Viruses | 2023 | 38005826 | PubTator, text mining | PubMed |
| Good Cop, Bad Cop: Profiling the Immune Landscape in Multiple Myeloma. | Biomolecules | 2023 | 38002311 | PubTator, text mining | PubMed |
| Methamphetamine (MA) use and MA-induced psychosis are associated with increasing aberrations in the compensatory immunoregulatory system, interleukin-1α, and CCL5 levels. | Transl Psychiatry | 2023 | 37996407 | PubTator, text mining | PubMed |
| γδ T cells: origin and fate, subsets, diseases and immunotherapy. | Signal Transduct Target Ther | 2023 | 37989744 | PubTator, text mining | PubMed |
| Molecular details of the CPSF73-CPSF100 C-terminal heterodimer and interaction with Symplekin. | Open Biol | 2023 | 37989222 | PubTator, text mining | PubMed |
| Early-to-mid stage idiopathic Parkinson's disease shows enhanced cytotoxicity and differentiation in CD8 T-cells in females. | Nat Commun | 2023 | 37985656 | PubTator, text mining | PubMed |
| CAR-T Cell Therapy: From the Shop to Cancer Therapy. | Int J Mol Sci | 2023 | 37958672 | PubTator, text mining | PubMed |
| Relapse of acute myeloid leukemia after allogeneic stem cell transplantation: immune escape mechanisms and current implications for therapy. | Mol Cancer | 2023 | 37951964 | PubTator, text mining | PubMed |
| Boosting cytotoxicity of adoptive allogeneic NK cell therapy with an oncolytic adenovirus encoding a human vIL-2 cytokine for the treatment of human ovarian cancer. | Cancer Gene Ther | 2023 | 37949944 | PubTator, text mining | PubMed |
| Unlocking the potential of allogeneic Vδ2 T cells for ovarian cancer therapy through CD16 biomarker selection and CAR/IL-15 engineering. | Nat Commun | 2023 | 37938576 | PubTator, text mining | PubMed |
| Themis2 regulates natural killer cell memory function and formation. | Nat Commun | 2023 | 37938555 | PubTator, text mining | PubMed |
| Adoptive cell therapy for cancer treatment. | Exploration (Beijing) | 2023 | 37933232 | PubTator, text mining | PubMed |
| Combinatorial blockade for cancer immunotherapy: targeting emerging immune checkpoint receptors. | Front Immunol | 2023 | 37928556 | PubTator, text mining | PubMed |
| γδ T cells as a potential therapeutic agent for glioblastoma. | Front Immunol | 2023 | 37928546 | PubTator, text mining | PubMed |
| NK cell subsets and dysfunction during viral infection: a new avenue for therapeutics? | Front Immunol | 2023 | 37928543 | PubTator, text mining | PubMed |
| PPARs at the crossroads of T cell differentiation and type 1 diabetes. | Front Immunol | 2023 | 37928539 | PubTator, text mining | PubMed |
| Impact of a new liver immune status index among patients with hepatocellular carcinoma after initial hepatectomy. | Ann Gastroenterol Surg | 2023 | 37927921 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10666/papers?page=20